Form 4: Q32 Bio Inc. Director, Mark T Iwicki, Acquires Stock Options

Director Mark T Iwicki acquired 25,534 stock options in Q32 Bio Inc. on March 25, 2024.

Summary

• Mark T Iwicki, a director of Q32 Bio Inc., acquired 25,534 stock options on March 25, 2024.
• The exercise price of these options is $16.82.
• One-third of the shares underlying the options will vest on March 25, 2025, with the remaining shares vesting in 24 equal monthly installments, contingent upon continued service.
• The options expire on March 24, 2034.
• Following the transaction, Iwicki directly owns 25,534 derivative securities.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard insider transaction. The vesting schedule suggests a long-term commitment, which is mildly positive.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule indicates a long-term incentive for the director to remain with the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, reflecting confidence from a company director.

Key Dates